• Generated on:
    This page was generated by TSDR on 2026-08-08 04:55:56 EDT
    Mark:
    IPGUAZU
    US Serial Number:
    99941910
    Application Filing Date:
    Jul. 15, 2026
    Filed as Base Application:
    Yes
    Currently Base Application:
    Yes
    Register:
    Principal
    Mark Type:
    Trademark
    TM5 Common Status Descriptor:
    TM5 Common Status image

    LIVE/APPLICATION/Awaiting Examination

    The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.

    Status:
    New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information.
    Status Date:
    Jul. 15, 2026
     

    Mark Information

    Mark Literal Elements:
    IPGUAZU
    Standard Character Claim:
    Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
    Mark Drawing Type:
    4 - STANDARD CHARACTER MARK

    Goods and Services

    Note: The following symbols indicate that the registrant/owner has amended the goods/services:
    • Brackets [..] indicate deleted goods/services;
    • Double parenthesis ((..)) identify any goods/services not claimed in a Section 15 affidavit of incontestability; and
    • Asterisks *..* identify additional (new) wording in the goods/services.
    For:
    Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorder, alopecia, Alzheimer's disease, asthma, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, cancer, cardiovascular disease, central nervous system diseases and disorders, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hearing loss, heart failure, infectious diseases, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, opioid use disorder, osteoarthritis, pain, Parkinson's disease, psoriasis, psoriatic arthritis, pulmonary diseases, retinal disease, rheumatoid arthritis, tobacco use disorder, ulcerative colitis, vascular diseases and vision loss; pharmaceutical preparations for weight management; vaccines for human use
    International Class(es):
    005 - Primary Class
    U.S Class(es):
    005, 006, 018, 044, 046, 051, 052
    Class Status:
    ACTIVE

    Basis Information (Case Level)

    Filed Use:
    No
    Currently Use:
    No
    Filed ITU:
    Yes
    Currently ITU:
    Yes
    Filed 44D:
    No
    Currently 44D:
    No
    Filed 44E:
    No
    Currently 44E:
    No
    Filed 66A:
    No
    Currently 66A:
    No
    Filed No Basis:
    No
    Currently No Basis:
    No

    Current Owner(s) Information

    Owner Name:
    Eli Lilly and Company
    Owner Address:
    Lilly Corporate Center
    Indianapolis, INDIANA UNITED STATES 46285
    Legal Entity Type:
    CORPORATION
    State or Country Where Organized:
    INDIANA

    Attorney/Correspondence Information

    Attorney of Record
    Attorney Name:
    Tiffany Trunko
    Attorney Primary Email Address:
    Attorney Email Authorized:
    Yes
    Correspondent
    Correspondent Name/Address:
    Tiffany Trunko
    Lilly Corporate Center
    Indianapolis, INDIANA United States 46285
    Phone:
    1-(332) 294-0505
    Correspondent e-mail:
    Correspondent e-mail Authorized:
    Yes
    Domestic Representative - Not Found

    Prosecution History

    Date Description Proceeding Number
    Jul. 15, 2026 APPLICATION FILING RECEIPT MAILED
    Jul. 15, 2026 NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
    Jul. 15, 2026 NEW APPLICATION ENTERED

    TM Staff and Location Information

    TM Staff Information
    TM Attorney:
    Law Office Assigned:
    Not Assigned
    File Location
    Current Location:
    Not Found
    Date in Location:
    Jul. 15, 2026